LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Conditions: Locally Advanced or Metastatic GC and GCJ Adenocarcinoma Interventions: Drug: LM-302; Drug: Apatinib; Drug: Irinotecan Sponsors: LaNova Medicines Zhejiang Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials